Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: Mol Cancer Ther. 2021 Sep 6;20(10):1769–1776. doi: 10.1158/1535-7163.MCT-21-0329

Figure 1. RET gene alterations and role on other cancer-causing pathways.

Figure 1.

RET mutations are seen as germline events in hereditary MEN syndrome and somatic RET mutations are seen in sporadic MTC. RET fusions are seen in NSCLC, papillary thyroid cancer and many other cancers.